CORC

浏览/检索结果: 共57条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy 期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:  Hua, Chen;  Shena, Lijuan;  Zoua, Fengming;  Wua, Yun;  Wanga, Beilei
收藏  |  浏览/下载:11/0  |  提交时间:2023/11/10
CDK9 inhibitors in cancer research 期刊论文
RSC MEDICINAL CHEMISTRY, 2022
作者:  Huang, Zhi;  Wang, Tianqi;  Wang, Cheng;  Fan, Yan
收藏  |  浏览/下载:7/0  |  提交时间:2022/12/23
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K-AKT-mTOR/JNK pathway 期刊论文
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 卷号: 53, 期号: 5, 页码: 575-583
作者:  Hu, Ke;  Li, Bo;  Ma, Ruye;  Yi, Hongfei;  Xu, Zhijian
收藏  |  浏览/下载:68/0  |  提交时间:2021/06/11
Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 211, 页码: 11
作者:  Qiu, Xiaqiu;  Li, Yuanqing;  Yu, Bin;  Ren, Jie;  Huang, Huidan
收藏  |  浏览/下载:21/0  |  提交时间:2021/05/24
CDK9  Antitumor  PROTAC  AML  Degrader  
Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 178, 页码: 782-801
作者:  Wang, Jubo;  Li, Tinghan;  Zhao, Tengteng;  Wu, Tizhi;  Liu, Chuang
收藏  |  浏览/下载:21/0  |  提交时间:2020/07/01
Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 卷号: 27, 期号: 23, 页码: 5332-5336
作者:  Fu, Yan;  Tang, Shuai;  Su, Yi;  Lan, Xiaojing;  Ye, Yan
收藏  |  浏览/下载:26/0  |  提交时间:2019/01/08
Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV 期刊论文
CURRENT PHARMACEUTICAL DESIGN, 2017, 卷号: 23, 期号: 29, 页码: 4369-4389
作者:  Cheng, Yong;  Schorey, Jeffrey S.;  Zhang, Cheng-Cai;  Tan, Xuejuan
收藏  |  浏览/下载:12/0  |  提交时间:2019/07/03
Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies 期刊论文
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 卷号: 17, 期号: 5
作者:  Guan, Haixing;  Du, Yongli;  Han, Weiwei;  Shen, Jingkang;  Li, Qunyi
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies 期刊论文
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 卷号: 17, 期号: 5, 页码: 646-657
作者:  Guan, Haixing;  Du, Yongli;  Han, Weiwei;  Shen, Jingkang;  Li, Qunyi
收藏  |  浏览/下载:19/0  |  提交时间:2019/01/08
An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 21, 页码: 9575-9598
作者:  Wang, Ying-Qing;  Wang, Ping-Yuan;  Wang, Yu-Ting;  Yang, Guang-Fu;  Zhang, Ao
收藏  |  浏览/下载:15/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace